SBI, Dr. Reddy's Labs, UltraTech Cement And More: Top Stock Picks For December By KRChoksey
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
KRChoksey Research Report
Investment period: six months. Research idea: Fundamental
ICICI Bank Ltd. - Strong profitability with healthy balance sheet.
State Bank of India - Best positioned to capture growth opportunities.
Dr Reddy's Laboratories Ltd. - Potential Covid-19 products’ sales and approval of generic for blockbuster Revlimid to drive growth.
Aurobindo Pharma Ltd. - Stabilisation in the competitive pressures in the U.S. and improved products mix to drive growth.
Ultratech Cement Ltd. - Best play in the cement space; outlook remains healthy.
Devyani International Ltd. - Best pick on platter, Bon appetit.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.